|Bid||16.61 x 800|
|Ask||39.00 x 900|
|Day's Range||28.67 - 30.96|
|52 Week Range||24.97 - 42.00|
|Beta (3Y Monthly)||1.40|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Beacon Roofing (BECN) delivered earnings and revenue surprises of -25.81% and -3.42%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Beacon Roofing (BECN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
For investors, following insiders can be a viable trading strategy. Corporate officers, board members, and investment funds are indeed careful about the way they allocate funds, so following their purchase activity can lead to great investment tips. More importantly, these are the entities with a more direct knowledge of the companies and business sectors. And they put that knowledge to use when planning stock purchases.TipRanks offers the Insiders’ Hot Stocks, a data tool that tracks over 43,000 corporate insiders and reveals their latest moves. We’ve used it to find three affordably priced stocks that are showing positive insider signals. Looking for the stocks, we used the Major Event Strategy, the most successful of four filters available on TipRanks for sorting insider trades.Insider Trading Strategies Sinclair Broadcast Group, Inc. (SBGI)Sinclair is the largest TV operator in the US, reaching 40% of American households with 193 stations in 100 local markets. The network is focused mainly in the Midwest and South. TV, with its advertising reach, is a lucrative business and Sinclair generated revenues over $3 billion in FY2018.Executive Chairman David D. Smith, son of the company’s founder, made the most recent insider purchase of SBGI stock, buying $21.7 million worth on July 10. The purchase increased his holding in the company by 395,000 shares, making him one of the largest shareholders in Sinclair.This insider purchase came just one day before five-star analyst Daniel Kurnos, of Benchmark, affirmed his buy rating and $90 price target on the stock. Smith’s purchase, and Kurnos’s review, come after the company publicized Q2 revenue guidance of $721 million – in line with previous estimates, and one month before the August 8 Q2 earnings release. In his note to investors, Kurnos says, “Sinclair completed the RSN-Charter (CHTR) negotiations, that Dish (DISH) remains the biggest "wildcard" for the RSNs, but he is optimistic Sinclair will prevail.” His price target, with its 52% upside for the stock, reflects his optimism.Overall, Sinclair has a strong buy analyst consensus rating, with a unanimous 5 buys over the past three months. Shares are selling for $59, and the $69 average price target indicates an 18% upside potential.>>Click Here to see the full list of Analyst Ratings Eidos Therapeutics, Inc. (EIDX)Biotech offers great opportunity it any company able to find a solid niche. Eidos Therapeutics focuses on developing new treatments for the two forms of transthyretin (TTR) amyloidosis (ATTR) disease. While the two disease forms – cardiomyopathy and polyneuropathy – manifest differently, they share the same cause. Eidos is working on a drug, AG10, designed to stabilize the malformed protein (TTR) that causes ATTR disease.Research of this type requires a great deal of capital, and that can be raised through stock sales. Recently, on July 8, Eidos received a capital infusion greater than $100 million, when four major stock owners increased their holdings. BridgeBio Pharma, the parent company of Eidos, along with three top company officers – Neil Kumar, CEO, and Ali Satvat and Eric Aguiar, both on the Board of Directors – all purchased $26.3 million worth of EIDX common shares. The transactions brought the total corporate insider purchases of EIDX in the last three months to $218.35 million – a clear vote of confidence by company officers in Eidos’ research pipeline and future prospects.Their optimism is borne out by a recent analyst review. Yasmeen Rahimi, of Roth Capital, believes “Eidos Therapeutics to maintain and even expedite enrollment into its Phase 3 ATTRibute-CM trial.” She also notes “an increase in AG10's annual price from $150,000 to $225,000 and Probability of Success adjustment from 70% to 80%.” In line with the upbeat prospects for the drug, she boosted her price target on EIDX by 45%, from $28 to $51. Her new price target suggests an upside potential of 27% for the stock.In the last three months, Eidos as received 2 buy ratings, giving it a moderate buy from the analyst consensus. The average price target of $44.50 suggests an 11% upside from the current share price of $39.97.>>Click Here to see the full list of Analyst Ratings Beacon Roofing Supply, Inc. (BECN)Economic experts predict that the US housing market, which has shown a slowing trend since 2017, will continue to weaken into 2020. Slowing population growth, combined with lower incomes and higher debt levels among the millennial age cohort, are putting downward pressure on housing starts.But there is always some demand for new housing, and construction companies like Beacon Roofing, North America’s largest supplier of roofing products to the residential and commercial construction sectors, will always have customers. This optimistic outlook is borne out by Cd&R Investment Associates IX recent purchase, back on June 28, of $158 million worth of BECN stock. A purchase of this size, by an investment group, is a clear signal of confidence in the stock.A look at the analyst reviews will help to explain the confidence. SunTrust’s Keith Hughes said, on March 26, “that while adverse weather factors reduced expectations, the outlook for the rest of the year suggests minimal impact in future quarters. [R]oofing can actually see benefits from weather factors over the medium term as replacement demand rises.” Hughes set a price target of $44, suggesting an upside of 18%.Weighing in just last month, Raymond James analyst Sam Darkatsh concurred on the buy rating, and gave BECN a $40 price target.BECN’s analyst consensus rating is a moderate buy, with 1 buy and 2 hold ratings given in the last 90 days. Shares are selling for $37.20, so the average price target of $40 indicates a possible 7.5% upside.>>Click Here to see the full list of Analyst RatingsVisit TipRanks’ Insiders’ Hot Stocks, and find your own best investment.
Beacon Roofing Supply, Inc. (NASDAQ:BECN) is a small-cap stock with a market capitalization of US$2.6b. While...
Fastenal (FAST) adopts FAST Solutions, an industrial vending process, which has the potential to revolutionize the industrial distribution system and increase profitability.
Beacon Roofing Supply Inc NASDAQ/NGS:BECNView full report here! Summary * Bearish sentiment is moderate and declining * Economic output in this company's sector is contracting Bearish sentimentShort interest | PositiveShort interest is moderate for BECN with between 5 and 10% of shares outstanding currently on loan. However, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on May 16. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold BECN had net inflows of $583 million over the last one-month. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managersâ€™ Index (PMI) data, output in the Consumer Servicesis falling. The rate of decline is significant relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Beacon Roofing (BECN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Back in 1997, Paul Marshall and Ian Wace launched their own hedge fund called Marshall Wace. The fund is headquartered in London, England while providing additional offices in New York, and Hong Kong. The fund’s investment philosophy combines quantitative strategies with basic investment principles for the purpose of delivering strong returns to its clients. Its […]
The annual Fortune 500 list — a tangible representation of business mite — hit the internet today with a gain for Greater Washington. Beacon Roofing Supply, a publicly traded company that moved from Massachusetts to Herndon in 2013, cracked the top 500 public U.
On a per-share basis, the Herndon, Virginia-based company said it had a loss of $1.08. Losses, adjusted for costs related to mergers and acquisitions, were 45 cents per share. The results beat Wall Street ...